AN UNBIASED VIEW OF PENTOBARBITAL SODIUM IN HUMANS

pentobarbital decreases effects of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may well decrease sufentanil stages and efficacy, possibly precipitating withdrawal syndrome in individuals that have created Bodily dependence to sufentanil. Disco